The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland and the USA, and is commercialized by Newron’s Partner Zambon. US WorldMeds holds the commercialization rights in the USA. Meiji Seika, in collaboration with Eisai, has the rights to develop and commercialize the compound in Japan and other key Asian territories. In addition to Xadago® for Parkinson’s disease, Newron has a strong pipeline of promising treatments for rare disease patients at various stages of clinical development, including sarizotan for patients with Rett syndrome and ralfinamide for patients with specific rare pain indications. Newron is also developing Evenamide as the potential first add-on therapy for the treatment of patients with positive symptoms of schizophrenia. Founded in 1999, Newron is headquartered in Bresso, near Milan, Italy, with a subsidiary in Morristown, NJ, USA. The Company is listed on the SIX Swiss Exchange, trading symbol NWRN.

TNO is an independent research organization with approximately 3,000 employees. They believe in joint creation of value in social and economic terms. They focus on transitions or changes in five social themes: Industry, Healthy Living, Defense & Safety, Environment and Energy. Targeted innovation, which is what TNO stands. They develop knowledge not about knowledge, but about practical application.

Swenora Biotech AB is a Swedish private company located in Stockholm that provides science and technology research and development services.

Boston Scientific Neuromodulation Corp. offers implantable pain management devices for neuromodulation. The company is headquartered in Marlborough, MA.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Part of Danone SA, Nutricia NV is a Dutch company located in Zoetermeer that manufactures dry, condensed and evaporated dairy products.

O.N. Diagnostics offers patient care, scientific research, drug development and medical device design.

Nexstim Oyj engages in the provision of medical technology products. It focuses on SmartFocus product, a navigated transcranial magnetic stimulation (nTMS) technology with sophisticated three-dimensional (3D) navigation providing accurate and personalized targeting of the TMS to the specific area of the brain. The company was founded by Risto Ilmoniemi and Pekka Puolakka on May 15, 2000 and is headquartered in Helsinki, Finland.

Nestec SA, a subsidiary of Nestlé SA, is a Swiss company located in Vevey. The firm manufactures nutrition food products.

Manufactures healthcare equipment

Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine. It focuses on the development of therapeutic products to treat neurology, oncology, cardiology, metabolic diseases, ophthalmology, orthopedics, and blood and vascular diseases. It is also developing human embryonic stem cell programs, including cell lines and a Phase I clinical trial in patients with acute spinal cord injury; intellectual property related to its autologous cellular immunotherapy program, including a Phase I/II clinical trial of autologous immunotherapy in patients with acute myelogenous leukemia; and non-therapeutic applications of pluripotent stem cells, such as cellular assay products for use in drug development and toxicity screening. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is based in Menlo Park, California.

For more than 60 years, HRL's scientists and engineers have been on the leading edge of technology, conducting pioneering research, providing real-world technology solutions, and advancing the state of the art. They continue to be recognized as one of the world's premier physical science and engineering research laboratories. Their research collaborations with their LLC Member companies, government, commercial and academic institutions are realizing groundbreaking advances in ultra-high-performance circuitry, robust computing and communications, automated data extraction, and innovative architected materials. Their technologies operate in space, on aircraft, in automobiles, and in a variety of consumer products. These technologies make us safer, support their national security and improve their quality of life. Their success is the result of their collaborative team of researchers, many of whom are the leading experts in their fields. Through their insights in support for their customers, they are finding the unique opportunities in technology. As they look to the future, the technologies they are enabling today will be integral to a prosperous, secure, sustainable world.

Quibim, with headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis. Quibim products are used worldwide by leading pharmaceutical companies and research teams. Partners use Quibim Precision®, a whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of novel treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers. We understand every body part. We speak human.

Baofeng Biotechnology (Beijing) Co., Ltd., established on 2012-08-30, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;flower planting;Landscaping engineering construction;Conference and Exhibition Services;Health Consulting Services(Does not include medical services);software development;marketing planning;Organize cultural and artistic exchange activities;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Import and export;Technology Import and Export;tree planting business;Office Supplies Sales;General merchandise sales;Mold Sales;brand management;sales agent;Retailing of computer software, hardware and auxiliary equipment;Cosmetics Wholesale;internet sales(Except for products that require a license for sale);data processing services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:food sales;Drug Wholesale;Class III medical device business;Drug retail;food production;Health food production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.

StimScience is an Electroceuticals company that develops all common types of tES including transcranial direct current stimulation, transcranial alternating current stimulation, transcranial random noise stimulation. The company's NeuroMod tXES system allows the user to create any arbitrary waveform for use in tES. StimScience was founded in 2017 and is based in Berkeley, California.

Shenzhen Iridium Medical Technology Co., Ltd., established on 2017-06-08, Business scope includes general business items:R&D of medical devices,technical consulting;Medical clinical research technical service;Medical Research and Experimental Development;Technical development of medical science and technology and related technical consultation,Technical Services,Transfer of self-owned technological achievements;computer system integration;database processing;Leasing of own medical equipment;the first sort,Sales of Class II medical consumables;engaged in import and export business(law,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council).Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Health Consulting Services(Does not include medical services);Sales of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Class II medical consumables,Sales of Class III Medical Consumables;one,two,Production of Class III Medical Devices;Class III medical device sales;insurance agent.Sales of Class II Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)